Difference between revisions of "Help:Assembly standard 25"

(Proposal)
(Prefix)
Line 37: Line 37:
  
 
===Prefix===
 
===Prefix===
<div style="border-style: solid; border-width: 1px; padding-left: 4px; padding-right: 4px; padding-top: 1px; padding-bottom: 1px">
+
Freiburg standard FusionPrefix (<font color="#cc00ff">EcoRI</font>, NotI,<font color="#ff5333"> XbaI</font>,<font color="#bababa"> </font><font color="#009999">NgoMIV</font>,<font color="#bababa"> part in gray</font>; original BioBrick prefix for coding sequences underlined):
BioBrick 3.0 FusionPrefix (<font color="#cc00ff">EcoRI</font>, NotI,<font color="#ff5333">  
+
 
XbaI</font>,<font color="#bababa"> </font><font color="#009999">NgoMIV</font>,<font color="#bababa"> part in gray</font>;  
+
<b><span style="font-family: monospace; font-size: 125%; padding-left: 1em;"><u><font color="#cc00ff">gaattcc</font>gcggccgct</u><font color="#ff5333"><u>tctag</u>a</font>tg<font color="#009999">gccggc</font><font color="#bababa">CA...</font></span></b>
original BioBrick prefix for coding sequences underlined):<p><b><span style="font-family: monospace; font-size: 125%; padding-left: 1em;">
+
 
<u>
+
Freiburg standard N-partPrefix is identical to the BioBrick prefix for coding sequences (<font color="#cc00ff">EcoRI</font>, NotI,<font color="#ff5333"> XbaI</font>,<font color="#bababa"> part in gray)</font>:
<font color="#cc00ff">gaattcc</font>gcggccgct</u><font color="#ff5333"><u>tctag</u>a</font>tg<font color="#009999">gccggc</font><font color="#bababa">CA...</font></span></b>
+
 
</p><p>BioBrick 3.0 N-partPrefix is identical to the BioBrick prefix for coding  
+
<b><span style="font-family: monospace; font-size: 125%; padding-left: 1em;"><font color="#cc00ff">gaattcc</font>gcggccgct<font color="#ff5333">tctag</font><font color="#bababa">ATG...</font></span></b>
sequences (<font color="#cc00ff">EcoRI</font>, NotI,<font color="#ff5333">  
+
XbaI</font>,<font color="#bababa"> part in gray)</font>:</p>
+
<p><b><span style="font-family: monospace; font-size: 125%; padding-left: 1em;">
+
<font color="#cc00ff">gaattcc</font>gcggccgct<font color="#ff5333">tctag</font><font color="#bababa">ATG...</font></span></b>
+
</p></div>
+
  
 
===Suffix===
 
===Suffix===

Revision as of 04:28, 2 February 2009

Introduction

The generalized BioBrick prefix and suffix with its easy cloning strategy is an excellent and universal way to combine various parts, e.g. promoter region, gene of interest, terminator etc. However, it is not well-suited for in-frame assembly of protein domains due to the 8 bp SpeI/XbaI scar.

Suffix of the first part (part in gray, PstI, NotI, SpeI):

...ACtactagtagcggccgctgcag

combined with Prefix of the second part (EcoRI, NotI, XbaI,part in gray):

gaattccgcggccgcttctagagCA...

results after an SpeI/Xba combination in:

...ACtactagagCA...

encoding the amino acids Tyr (codon: <codon>tac</codon>), STOP (codon: tag) and Ser or Arg (codon agn).

Consequently, protein domains cannot be designed as separate BioBrick parts and assembled together. The Freiburg assembly standard was developed to address this shortcoming while retaining compatibility with the original BioBrick version. The Freiburg standard extends the original BioBrick standard with two additional compatible restriction sites to allow for the modular assembly of protein fusion parts. For the Freiburg standard, appropriate enzymes were chosen carefully to include ensure coding for amino acids which are compatible with flexible linkers as well as with the N-end rule for protein stability.

Proposal

The Freiburg assembly standard extends the original BioBrick suffix and prefix with two additional compatible restriction sites. The frame of the standard suffix and prefix remains the same resulting in complete compatibility with any previously designed parts. We chose the restriction sites NgoMVI and AgeI as they code for the amino acids Ala-Gly or Thr-Gly, respectively, which are compatible with flexible linkers commonly used in fusion proteins and also compatible with the N-end rule for protein stabiliy. Consequently, we name these parts FusionParts. Assembly of two parts that adhere to the Freiburg assembly standard creates an AgeI/NgoMIV scar coding for Thr-Gly, which can easily be integrated in any linker sequence. Furthermore, the NgoMIV site (coding for Ala-Gly) after the start Methionine of the standard BioBrick suffix adheres completely to the N-end rule. For proteins, which are sensitive to amino acid addition at the N-terminus, we also devised an N-Part with a suffix that lacks the NgoMIV site.

The following list summarizes the most important aspects of the Freiburg assembly standard.

  • Both parts, the FusionPart and the N-part are fully compatible with all standard iGEM parts as they have the BioBricks prefix for coding sequences and the standard BioBrick suffix.
  • Both parts have two additional enzymes, NgoMIV and AgeI, which have compatible cohesive ends and enable in-frame fusion of protein parts with the linker sequence TG (no stop codons).
  • The only difference of the N-part and FusionPart is the additional NgoMIV site in the FusionPart.
  • The FusionPart is the universal part for fusion proteins, and it can be a stand-alone protein part as it has a start codon after the XbaI site (BioBrick prefix for coding sequence), with two additional amino acids (A, G) encoded before the start of the protein.
  • The N-part is designed to be the start of a fusion protein or a stand-alone protein part, in which the N-terminus is sensitive to any amino acid addition, to be cloned via XbaI/PstI to any iGEM RBS expression part.
  • The FusionPart can be fused to the N-part by digesting the N-part with AgeI/SpeI and the FusionPart with NgoMIV/SpeI.
  • Any number of FusionParts can be combined and optionally fused to the N-part.
  • nnnnnn is a place holder for the coding sequence of the respective part.


Prefix

Freiburg standard FusionPrefix (EcoRI, NotI, XbaI, NgoMIV, part in gray; original BioBrick prefix for coding sequences underlined):

gaattccgcggccgcttctagatggccggcCA...

Freiburg standard N-partPrefix is identical to the BioBrick prefix for coding sequences (EcoRI, NotI, XbaI, part in gray):

gaattccgcggccgcttctagATG...

Suffix

BioBrick 3.0 FusionSuffix (part in gray, AgeI, SpeI, NotI,

PstI; original BioBrick suffix underlined):

...ACaccggttaatactagtagcggccgctgcag

 

Combining the respective prefix and suffix generates the following FusionPart and N-part:


FusionPart


                          NaeI     BsrFI                    SfcI
 ApoI                  BsrFI |     BsaWI                 MspA1I|
EcoRI   NotI    XbaI  NgoMIV |      AgeI      SpeI    NotI    ||PstI
    |      |       |       | |         |         |       |    ||   |
    GAATTCgcggccgctTCTAGAtgGCCGGCnnnnnnACCGGTtaatACTAGTagcggccgCTGCAG
  1 ---------+---------+---------+---------+---------+---------+----- 65
    CTTAAGcgccggcgaAGATCTacCGGCCGnnnnnnTGGCCAattaTGATCAtcgccggcGACGTC
c     I  R  G  R  F  *  M  A  G  ?  ?  T  G  *  Y  *  *  R  P  L  Q   -


N-part


                             BsrFI                    SfcI
 ApoI                        BsaWI                 MspA1I|
EcoRI   NotI    XbaI          AgeI      SpeI    NotI    ||PstI
    |      |       |             |         |       |    ||   |
    GAATTCgcggccgctTCTAGAtgnnnnnnACCGGTtaatACTAGTagcggccgCTGCAG
  1 ---------+---------+---------+---------+---------+--------- 59
    CTTAAGcgccggcgaAGATCTacnnnnnnTGGCCAattaTGATCAtcgccggcGACGTC
c     I  R  G  R  F  *  M  ?  ?  T  G  *  Y  *  *  R  P  L  Q   -

<p>

References

  • NgoMIV NEB information
  • Nishikubo T, Nakagawa N, Kuramitsu S, Masui R "Improved heterologous gene expression in Escherichia coli by optimization of the AT-content of codons immediately downstream of the initiation codon." J Biotechnol. 2005 Dec 6;120(4):341-6
  • Pfleger BF, Fawzi NJ, Keasling JD "Optimization of DsRed production in Escherichia coli: effect of ribosome binding site sequestration on translation efficiency." Biotechnol Bioeng. 2005 Dec 5;92(5):553-8
  • Varshavsky A "The N-end rule: functions, mysteries, uses." Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12142-9 [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=8901547&ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum pubmed]